Advertisement

Picture EBD Group BIO-Europe 2019 Partnering Report BEU2019 650x80px
Organisation › Details

Humanwell Healthcare (Group)

Yichang Humanwell Pharmaceutical Co. is part of Wuhan Humanwell healthcare (Group) Co., Ltd an industrial group giving priority to the medical health business, specializes in the development, production, distribution and technical support of pharmaceutical, medical instruments and reproductive healthcare products and technologies. Yichang Humanwell is the largest company to develop and produce narcotic products in China. *

 

Period Start 2012-03-22 existent
Products Industry pharmaceutical
  Industry 2 medical device
     
  City n. a. Wuhan
    Address record changed: 2012-04-03
     
Basic data Employees n. a.
     
    * Document for �About Section�: Paion AG. (3/22/12). "Press Release: Paion Signed Exclusive Option Agreement with Yichang for Remimazolam in China. Upfront Payments in the Total Amount of EUR 3 Million Subject to Signing of the Final Licensing Agreement". Aachen.
     
   
Record changed: 2019-06-09

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Humanwell Healthcare (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2019 Partnering Report BEU2019 650x80px




» top